Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis

✍ Scribed by D. C. METZ; C. W. HOWDEN; M. C. PEREZ; L. LARSEN; J. O’NEIL; S. N. ATKINSON

• Book ID: 108605580
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 205 KB
• Volume: 29
• Category: Article
• ISSN: 0269-2813
• DOI: 10.1111/j.1365-2036.2009.03954.x